Weekly versus tri‐weekly paclitaxel with carboplatin for first‐line treatment in women with ovarian cancer

ABSTRACT: Abstract This is the protocol for a review and there is no abstract. The objectives are as follows: To compare the effectiveness and safety of weekly paclitaxel with that of three‐weekly paclitaxel, in combination with carboplatin, as first‐line chemotherapy treatment for ovarian cancer.

SUBMITTER: Syn N 

PROVIDER: S-EPMC6457624 | biostudies-literature | 2015 Dec

REPOSITORIES: biostudies-literature